Get started
Zai Lab LimitedZai Lab LimitedZai Lab Limited

Zai Lab Limited

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.78 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.61 USD
Net income (FY)
‪−176.00 M‬ USD
Revenue (FY)
‪461.37 M‬ USD
Shares float
‪110.76 M‬
Beta (1Y)
1.76

About Zai Lab Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Ying Du
Website
zailaboratory.com
Headquarters
Shanghai
Founded
2014
IPO date
Sep 28, 2020
Identifiers
3
ISIN US98887Q1040
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Check out other big names from the same industry as ZLAB.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IBB
iShares Biotechnology ETF
Weight 0.18%
Market value ‪15.55 M‬
CANC
Tema Oncology ETF
Weight 2.82%
Market value ‪5.25 M‬
SBIO
ALPS Medical Breakthroughs ETF
Weight 1.60%
Market value ‪2.27 M‬
BBP
Virtus Biotech ETF
Weight 2.11%
Market value ‪1.29 M‬
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight 0.07%
Market value ‪654.94 K‬
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight 0.07%
Market value ‪654.94 K‬
PGJ
Invesco Golden Dragon China ETF
Weight 0.52%
Market value ‪618.63 K‬
FMED
Fidelity Disruptive Medicine ETF
Weight 1.01%
Market value ‪617.08 K‬
SBIO
Invesco NASDAQ Biotech UCITS ETF
Weight 0.07%
Market value ‪282.36 K‬
ZEM
BMO MSCI Emerging Markets Index ETF
Weight 0.01%
Market value ‪282.22 K‬
NSI
National Security Emerging Markets Index ETF
Weight 0.28%
Market value ‪116.83 K‬

Explore more ETFs